By Image Solutions, Inc.

closed 1/12/2011 via BusinessWire

Computer Sciences Corporation, acquired Image Solutions, Inc.

See 337 Comparable Transactions
synopsis: Computer Sciences Corporation announced it has closed the acquisition of Image Solutions, Inc. (ISI), a privately-held, global leader in regulatory submission management solutions and related implementation and outsourcing services for the Life Sciences sector.
buyer: Computer Sciences Corporation (DXC:$18,892.00)
Computer Sciences Corporation is a global leader in providing technology-enabled solutions and services through three primary lines of business. These include Business Solutions & Services, the Managed Services Sector and the North American Public Sector. "
 target: Image Solutions, Inc.
Founded in 1992, Image Solutions, Inc. is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/19/2009 via BusinessWire

Apyx, Inc. merged with Image Solutions, Inc.,

See 337 Comparable Transactions
synopsis: ISI, a leading provider of software and services for the life sciences industry, announced that it has acquired Apyx, Inc. The merger adds muscle to ISI’s already-growing professional services business, and enhances the company’s broad range of offerings in submissions management and outsourcing.
buyer: Image Solutions, Inc.
Founded in 1992, Image Solutions, Inc. (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. "
 target: Apyx, Inc.
Apyx, Inc. provides regulatory strategy and submission management tools and services to help Life Science companies expedite the regulatory submission process, reduce associated expenses and improve document and overall submission quality.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/12/2011 via BusinessWire

Computer Sciences Corporation, acquired Image Solutions, Inc.

See 337 Comparable Transactions
synopsis: Computer Sciences Corporation announced it has closed the acquisition of Image Solutions, Inc. (ISI), a privately-held, global leader in regulatory submission management solutions and related implementation and outsourcing services for the Life Sciences sector.
buyer: Computer Sciences Corporation (DXC:$18,892.00)
Computer Sciences Corporation is a global leader in providing technology-enabled solutions and services through three primary lines of business. These include Business Solutions & Services, the Managed Services Sector and the North American Public Sector. "
 target: Image Solutions, Inc.
Founded in 1992, Image Solutions, Inc. is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/19/2009 via BusinessWire

Apyx, Inc. merged with Image Solutions, Inc.,

See 337 Comparable Transactions
synopsis: ISI, a leading provider of software and services for the life sciences industry, announced that it has acquired Apyx, Inc. The merger adds muscle to ISI’s already-growing professional services business, and enhances the company’s broad range of offerings in submissions management and outsourcing.
buyer: Image Solutions, Inc.
Founded in 1992, Image Solutions, Inc. (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. "
 target: Apyx, Inc.
Apyx, Inc. provides regulatory strategy and submission management tools and services to help Life Science companies expedite the regulatory submission process, reduce associated expenses and improve document and overall submission quality.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2013 via Company Press Release

Litéra Corp, purchased AxxiTRIALS from Axxiem Web Solutions

See 209 Comparable Transactions
synopsis: Litera has announced the acquisition of AxxiTRIALS from Axxiem Web Solutions. AxxiTRIALS is a leading Clinical Trials Portal solution providing life science companies and clinical research organizations (CROs) with a platform designed to dramatically speed site start-up, patient recruitment, and end-to-end clinical trial operations.
buyer: Litéra Corp
Litéra Corp. engages in developing and marketing content lifecycle management solutions for law firms and corporations worldwide. It offers document creation, comparison, collaboration, and cleansing software solutions that manage documents throughout their lifecycle. "
 seller: Axxiem Web Solutions
AxxiTRIALS developed by Axxiem is a web-based clinical trials communication portal. AxxiTRIALS provides a simple and secure way to efficiently distribute and track time-sensitive documents and training materials to users around the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2008 via BusinessWire

Bio-Imaging Technologies, Inc., acquired Phoenix Data Systems Inc.

See 209 Comparable Transactions
synopsis: Bio-Imaging Technologies, Inc. it has acquired privately held Phoenix Data Systems, Inc., a leading global clinical data services provider of electronic data capture services and a comprehensive array of broadly interoperable eClinical data solutions to the pharmaceutical and biotechnology industries.
buyer: Bio-Imaging Technologies, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
 target: Phoenix Data Systems Inc.
Phoenix Data Systems delivers Full Service EDC, a unique combination of electronic data capture, interactive voice response, reporting, and data management services that give clinical data managers improved control to run well-managed studies.
price ($mm)[EV]
$19 [$18]
rev ($mm)
$12
EBITDA ($mm)
$1
EV / rev
1.8x
EV / EBITDA
15.4x
closed 10/28/2014 via Company Press Release

Medidata Solutions Worldwide, acquired Patient Profiles, LLC

See 338 Comparable Transactions
synopsis: Medidata Solutions, the leading global provider of cloud-based solutions for clinical research in life sciences, announced it has acquired Patient Profiles, LLC. They are an early-stage software company focused on clinical data analytics in clinical trials.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion. "
 target: Patient Profiles, LLC
Patient Profiles, LLC was founded in 2013 to develop software to improve the efficiency of clinical trials. The Company’s “Patient Profiles” software makes individual reports for every patient in a clinical trial.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/3/2014 via PR Newswire

TrialScope, acquired PharmaCM

See 338 Comparable Transactions
synopsis: TrialScope, a provider of clinical trial solutions and services, announced its acquisition of substantially all of the assets of Deloitte Analytics LLC, including the PharmaCM business which provides technology solutions for clinical trial registration and transparency.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
 target parent: Deloitte LLP
target: PharmaCM
PharmaCM is a content management platform designed specifically for the regulated environment of Life Sciences. The PharmaCM platform is the basis for a number of modules developed to address specific content management and workflow challenges across the clinical and regulatory content value chain.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/4/2021 via PR Newswire

Clarivate plc, acquired Bioinfogate S.L.

See 406 Comparable Transactions
synopsis: Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X™ portal.
buyer: Clarivate plc (:$1,614.03)
Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Clarivate helps customers discover, protect and commercialize their inventions using its trusted subscription and technology-based solutions coupled with deep domain expertise. "
 target: Bioinfogate S.L.
Bioinfogate is a leading provider of analytics solutions in the life sciences and producer of the OFF-X portal, a safety intelligence solution aimed at empowering pharmaceutical organizations to identify toxicology and safety signals, mitigate safety liabilities and de-risk early-stage assets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/16/2021 via BusinessWire

Exscientia, will acquire Allcyte

See 343 Comparable Transactions
synopsis: UK-based Exscientia, a clinical stage pharmatech company, will acquire Allcyte, an Austrian leader in AI-based precision medicine. The combination expands Exscientia’s translational capabilities by enabling high content evaluation of individual patient biology in primary tumour tissues, rather than artificial cell lines or animal models.
buyer: Exscientia
Based in the UK, Exscientia is an AI-driven pharmatech company committed to discovering and designing the best possible medicines in the fastest and most effective manner. Exscientia is the first company to progress AI-designed small molecules into the clinical setting. "
 target: Allcyte
Based in Austria, Allcyte is a leader in artificial intelligence (AI) based precision medicine. Allcyte’s technology is designed to select the most promising drug candidates for clinical development in the right patient populations to maximise clinical study success rates and patient benefit.
price ($mm)
$61
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

See 710 Comparable Transactions
synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
 target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2014 via PR Newswire

Decision Resources Group, acquired Relay Technology Management

See 223 Comparable Transactions
synopsis: Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Relay Technology Management
Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/4/2021 via GlobeNewswire

Certara, acquired Pinnacle 21

See 502 Comparable Transactions
synopsis: Certara, Inc., a global leader in biosimulation, announced the completion of the previously announced transaction to acquire Pinnacle 21, a leading provider of SaaS solutions for clinical data fitness, regulatory compliance and submission readiness.
buyer parent: EQT AB
buyer: Certara (:$261.77)
Certara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. "
 target: Pinnacle 21
Pinnacle 21 is a global leader in software for preparing clinical trial data for regulatory submission. Their platform validates data quality and compliance with CDISC standards, enabling a clean data pipeline from worldwide sponsors to health authorities, including the FDA, PMDA and NMPA.
price ($mm)
$310
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/13/2019 via BusinessWire

Saama Technologies, will acquire Comprehend Systems, Inc.

See 207 Comparable Transactions
synopsis: Saama Technologies, Inc., the advanced clinical data and analytics company, announced that it has signed a definitive agreement to acquire Comprehend Systems, Inc., a company that provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process.
buyer: Saama Technologies
Saama Technologies is the advanced clinical data and analytics company, unleashing wisdom from data to deliver better actionable business outcomes for the life sciences industry. "
 target: Comprehend Systems, Inc.
Comprehend provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process. Their solutions deliver actionable risk and performance insights across studies, systems, sites, and vendors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/15/2016 via PR Newswire

The WIRB-Copernicus Group, will purchase Clinical Trial Applications from karmadata

See 154 Comparable Transactions
synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality of clinical research, will acquire from karmadata a suite of proprietary applications designed to facilitate the management of clinical trial data. karmadata is the market leader in clinical trial database and decision support applications.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
 seller: karmadata
Karmadata is able to standardize and link the world's healthcare data ranging from leading open data sources to priva pharmacy and medical claims. Its propriety applications are designed to facilitate the management of clinical trial data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/6/2015 via BusinessWire

IMS Health Incorporated, acquired Dataline Software

See 103 Comparable Transactions
synopsis: IMS Health has acquired Dataline Software, a leader in Big Data analytics for healthcare. U.K.-based Dataline has worked closely with life sciences companies, payers, healthcare authorities and academia to deliver tailored software for rapid analysis and elegant visualizations of large, complex healthcare data sets.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
 target: Dataline Software
Dataline is a software solutions company specializing in big-data analytics solutions for healthcare. They also provide consultancy, training, system implementation, application development and technical support to a wide and varied client base.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2014 via Company Press Release

ERT, acquired eClinical Insights, Inc.

See 207 Comparable Transactions
synopsis: ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, announced the acquisition of eClinical Insights (eCI), an innovative provider of cloud-based clinical trials management software.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data. "
 target: eClinical Insights, Inc.
eClinical Insights® is a leading-edge provider of cloud-based clinical software that provides clinical research professionals with the strategic visibility to make rapid, data-driven decisions to positively impact the performance and cost of their clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2009 via PR Newswire

OmniComm Systems, Inc., purchased EDC Solutions from eResearch Technology, Inc.

See 207 Comparable Transactions
synopsis: OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, has acquired the EDC business of eResearchTechnology, Inc., a global provider of technology and services that enable life science industries worldwide to collect, interpret, and distribute cardiac safety and clinical data.
buyer: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm Systems, Inc. provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. "
 seller: eResearch Technology, Inc.
eResearchTechnology, Inc. (eRT) is a provider of technology-based products and services that enable the pharmaceutical, biotechnological, medical device, and contract resource companies to collect, interpret, and distribute cardiac safety and clinical data more efficiently.
price ($mm)[EV]
$2.02 [$0.87]
rev ($mm)
$6
EBITDA ($mm)
EV / rev
0.1x
EV / EBITDA
closed 7/15/2009 via BusinessWire

Merge Healthcare, acquired etrials, Inc.

See 207 Comparable Transactions
synopsis: Merge Healthcare Inc., a leading health IT solutions provider, and etrials Worldwide, Inc., a leading provider of clinical trials software and services, announced the expiration of the exchange offer for the shares of etrials’ common stock by Merge Acquisition Corp. Merge now owns approximately 86% of the outstanding shares of Etrials common stock.
buyer: Merge Healthcare (MRGE:$227.59)
Merge Healthcare Incorporated builds software solutions that automate healthcare data and diagnostic workflow to build a better electronic record of the patient experience. "
 target: etrials, Inc.
etrials has earned the loyalty of its healthcare partners by guiding them to simplify and accelerate the processes associated with collecting data in clinical trials. Using innovative technologies and proven business processes, etrials offers the most efficient data management products and services.
price ($mm)[EV]
$21 [$14]
rev ($mm)
$16
EBITDA ($mm)
EV / rev
0.9x
EV / EBITDA
closed 11/25/2020 via Company Press Release

Advarra, acquired Longboat Clinical Ltd.

See 284 Comparable Transactions
synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, is pleased to announce the acquisition of Longboat, an innovative provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
 target: Longboat Clinical Ltd.
Longboat is an innovative provider of user-friendly, fully mobile clinical research technology solutions that take the complexity out of trials for site staff, patients, monitors, and study teams, making protocol compliance easy and instinctive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/2/2020 via Company Press Release

Cytel Inc., acquired Laiya Consulting, Inc.

See 268 Comparable Transactions
synopsis: Cytel Inc. has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation. Laiya pioneered the delivery of trial design software using SaaS, which aligns with Cytel’s goal of making all of its design software available as a cloud-based service.
buyer parent: New Mountain Capital, LLC
buyer: Cytel Inc.
Cytel provides statistical software for clinical trials. Cytel provides an understanding of software tools that solve statistical problems and that meet the highest standards of reliability, technical documentation and customer support. "
 target: Laiya Consulting, Inc.
Founded in 2010, Laiya Consulting has supported drug developers to drive success rates and maximize portfolio returns through the design and implementation of Bayesian adaptive trials, robust clinical strategies, and integrated software platforms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/5/2016 via Company Press Release

Instem, acquired Notocord

See 376 Comparable Transactions
synopsis: Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it has acquired NOTOCORD. NOTOCORD provides software solutions for data acquisition and analysis in preclinical studies and is a recognized leader in cardiovascular, respiratory, electrophysiology and nervous system research areas.
buyer: Instem (AIM:INS:$38.90)
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide. "
 target: Notocord
Notocord, Inc. designs software and provides data acquisition, analysis, as well as reporting solutions. Their solutions are fit for preclinical R&D, including efficacy testing, early safety, regulatory safety pharmacology and toxicology studies.
price ($mm)
$2.25
rev ($mm)
$3
EBITDA ($mm)
EV / rev
2.0x
EV / EBITDA
Pages:  
closed 1/12/2011 via BusinessWire

Computer Sciences Corporation, acquired Image Solutions, Inc.

See 337 Comparable Transactions
synopsis: Computer Sciences Corporation announced it has closed the acquisition of Image Solutions, Inc. (ISI), a privately-held, global leader in regulatory submission management solutions and related implementation and outsourcing services for the Life Sciences sector.
buyer: Computer Sciences Corporation (DXC:$18,892.00)
Computer Sciences Corporation is a global leader in providing technology-enabled solutions and services through three primary lines of business. These include Business Solutions & Services, the Managed Services Sector and the North American Public Sector. "
 target: Image Solutions, Inc.
Founded in 1992, Image Solutions, Inc. is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/19/2009 via BusinessWire

Apyx, Inc. merged with Image Solutions, Inc.,

See 337 Comparable Transactions
synopsis: ISI, a leading provider of software and services for the life sciences industry, announced that it has acquired Apyx, Inc. The merger adds muscle to ISI’s already-growing professional services business, and enhances the company’s broad range of offerings in submissions management and outsourcing.
buyer: Image Solutions, Inc.
Founded in 1992, Image Solutions, Inc. (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. "
 target: Apyx, Inc.
Apyx, Inc. provides regulatory strategy and submission management tools and services to help Life Science companies expedite the regulatory submission process, reduce associated expenses and improve document and overall submission quality.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2013 via Company Press Release

Litéra Corp, purchased AxxiTRIALS from Axxiem Web Solutions

See 209 Comparable Transactions
synopsis: Litera has announced the acquisition of AxxiTRIALS from Axxiem Web Solutions. AxxiTRIALS is a leading Clinical Trials Portal solution providing life science companies and clinical research organizations (CROs) with a platform designed to dramatically speed site start-up, patient recruitment, and end-to-end clinical trial operations.
buyer: Litéra Corp
Litéra Corp. engages in developing and marketing content lifecycle management solutions for law firms and corporations worldwide. It offers document creation, comparison, collaboration, and cleansing software solutions that manage documents throughout their lifecycle. "
 seller: Axxiem Web Solutions
AxxiTRIALS developed by Axxiem is a web-based clinical trials communication portal. AxxiTRIALS provides a simple and secure way to efficiently distribute and track time-sensitive documents and training materials to users around the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2008 via BusinessWire

Bio-Imaging Technologies, Inc., acquired Phoenix Data Systems Inc.

See 209 Comparable Transactions
synopsis: Bio-Imaging Technologies, Inc. it has acquired privately held Phoenix Data Systems, Inc., a leading global clinical data services provider of electronic data capture services and a comprehensive array of broadly interoperable eClinical data solutions to the pharmaceutical and biotechnology industries.
buyer: Bio-Imaging Technologies, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
 target: Phoenix Data Systems Inc.
Phoenix Data Systems delivers Full Service EDC, a unique combination of electronic data capture, interactive voice response, reporting, and data management services that give clinical data managers improved control to run well-managed studies.
price ($mm)[EV]
$19 [$18]
rev ($mm)
$12
EBITDA ($mm)
$1
EV / rev
1.8x
EV / EBITDA
15.4x
closed 10/28/2014 via Company Press Release

Medidata Solutions Worldwide, acquired Patient Profiles, LLC

See Comparable Transactions
synopsis: Medidata Solutions, the leading global provider of cloud-based solutions for clinical research in life sciences, announced it has acquired Patient Profiles, LLC. They are an early-stage software company focused on clinical data analytics in clinical trials.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion. "
 target: Patient Profiles, LLC
Patient Profiles, LLC was founded in 2013 to develop software to improve the efficiency of clinical trials. The Company’s “Patient Profiles” software makes individual reports for every patient in a clinical trial.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/3/2014 via PR Newswire

TrialScope, acquired PharmaCM

See 338 Comparable Transactions
synopsis: TrialScope, a provider of clinical trial solutions and services, announced its acquisition of substantially all of the assets of Deloitte Analytics LLC, including the PharmaCM business which provides technology solutions for clinical trial registration and transparency.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
 target parent: Deloitte LLP
target: PharmaCM
PharmaCM is a content management platform designed specifically for the regulated environment of Life Sciences. The PharmaCM platform is the basis for a number of modules developed to address specific content management and workflow challenges across the clinical and regulatory content value chain.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/4/2021 via PR Newswire

Clarivate plc, acquired Bioinfogate S.L.

See 406 Comparable Transactions
synopsis: Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X™ portal.
buyer: Clarivate plc (:$1,614.03)
Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Clarivate helps customers discover, protect and commercialize their inventions using its trusted subscription and technology-based solutions coupled with deep domain expertise. "
 target: Bioinfogate S.L.
Bioinfogate is a leading provider of analytics solutions in the life sciences and producer of the OFF-X portal, a safety intelligence solution aimed at empowering pharmaceutical organizations to identify toxicology and safety signals, mitigate safety liabilities and de-risk early-stage assets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/16/2021 via BusinessWire

Exscientia, will acquire Allcyte

See 343 Comparable Transactions
synopsis: UK-based Exscientia, a clinical stage pharmatech company, will acquire Allcyte, an Austrian leader in AI-based precision medicine. The combination expands Exscientia’s translational capabilities by enabling high content evaluation of individual patient biology in primary tumour tissues, rather than artificial cell lines or animal models.
buyer: Exscientia
Based in the UK, Exscientia is an AI-driven pharmatech company committed to discovering and designing the best possible medicines in the fastest and most effective manner. Exscientia is the first company to progress AI-designed small molecules into the clinical setting. "
 target: Allcyte
Based in Austria, Allcyte is a leader in artificial intelligence (AI) based precision medicine. Allcyte’s technology is designed to select the most promising drug candidates for clinical development in the right patient populations to maximise clinical study success rates and patient benefit.
price ($mm)
$61
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

See 710 Comparable Transactions
synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
 target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2014 via PR Newswire

Decision Resources Group, acquired Relay Technology Management

See 223 Comparable Transactions
synopsis: Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
 target: Relay Technology Management
Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/4/2021 via GlobeNewswire

Certara, acquired Pinnacle 21

See 502 Comparable Transactions
synopsis: Certara, Inc., a global leader in biosimulation, announced the completion of the previously announced transaction to acquire Pinnacle 21, a leading provider of SaaS solutions for clinical data fitness, regulatory compliance and submission readiness.
buyer parent: EQT AB
buyer: Certara (:$261.77)
Certara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. "
 target: Pinnacle 21
Pinnacle 21 is a global leader in software for preparing clinical trial data for regulatory submission. Their platform validates data quality and compliance with CDISC standards, enabling a clean data pipeline from worldwide sponsors to health authorities, including the FDA, PMDA and NMPA.
price ($mm)
$310
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/13/2019 via BusinessWire

Saama Technologies, will acquire Comprehend Systems, Inc.

See 207 Comparable Transactions
synopsis: Saama Technologies, Inc., the advanced clinical data and analytics company, announced that it has signed a definitive agreement to acquire Comprehend Systems, Inc., a company that provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process.
buyer: Saama Technologies
Saama Technologies is the advanced clinical data and analytics company, unleashing wisdom from data to deliver better actionable business outcomes for the life sciences industry. "
 target: Comprehend Systems, Inc.
Comprehend provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process. Their solutions deliver actionable risk and performance insights across studies, systems, sites, and vendors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/15/2016 via PR Newswire

The WIRB-Copernicus Group, will purchase Clinical Trial Applications from karmadata

See 154 Comparable Transactions
synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality of clinical research, will acquire from karmadata a suite of proprietary applications designed to facilitate the management of clinical trial data. karmadata is the market leader in clinical trial database and decision support applications.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
 seller: karmadata
Karmadata is able to standardize and link the world's healthcare data ranging from leading open data sources to priva pharmacy and medical claims. Its propriety applications are designed to facilitate the management of clinical trial data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/6/2015 via BusinessWire

IMS Health Incorporated, acquired Dataline Software

See 103 Comparable Transactions
synopsis: IMS Health has acquired Dataline Software, a leader in Big Data analytics for healthcare. U.K.-based Dataline has worked closely with life sciences companies, payers, healthcare authorities and academia to deliver tailored software for rapid analysis and elegant visualizations of large, complex healthcare data sets.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
 target: Dataline Software
Dataline is a software solutions company specializing in big-data analytics solutions for healthcare. They also provide consultancy, training, system implementation, application development and technical support to a wide and varied client base.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2014 via Company Press Release

ERT, acquired eClinical Insights, Inc.

See 207 Comparable Transactions
synopsis: ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, announced the acquisition of eClinical Insights (eCI), an innovative provider of cloud-based clinical trials management software.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data. "
 target: eClinical Insights, Inc.
eClinical Insights® is a leading-edge provider of cloud-based clinical software that provides clinical research professionals with the strategic visibility to make rapid, data-driven decisions to positively impact the performance and cost of their clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2009 via PR Newswire

OmniComm Systems, Inc., purchased EDC Solutions from eResearch Technology, Inc.

See 207 Comparable Transactions
synopsis: OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, has acquired the EDC business of eResearchTechnology, Inc., a global provider of technology and services that enable life science industries worldwide to collect, interpret, and distribute cardiac safety and clinical data.
buyer: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm Systems, Inc. provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. "
 seller: eResearch Technology, Inc.
eResearchTechnology, Inc. (eRT) is a provider of technology-based products and services that enable the pharmaceutical, biotechnological, medical device, and contract resource companies to collect, interpret, and distribute cardiac safety and clinical data more efficiently.
price ($mm)[EV]
$2.02 [$0.87]
rev ($mm)
$6
EBITDA ($mm)
EV / rev
0.1x
EV / EBITDA
closed 7/15/2009 via BusinessWire

Merge Healthcare, acquired etrials, Inc.

See 207 Comparable Transactions
synopsis: Merge Healthcare Inc., a leading health IT solutions provider, and etrials Worldwide, Inc., a leading provider of clinical trials software and services, announced the expiration of the exchange offer for the shares of etrials’ common stock by Merge Acquisition Corp. Merge now owns approximately 86% of the outstanding shares of Etrials common stock.
buyer: Merge Healthcare (MRGE:$227.59)
Merge Healthcare Incorporated builds software solutions that automate healthcare data and diagnostic workflow to build a better electronic record of the patient experience. "
 target: etrials, Inc.
etrials has earned the loyalty of its healthcare partners by guiding them to simplify and accelerate the processes associated with collecting data in clinical trials. Using innovative technologies and proven business processes, etrials offers the most efficient data management products and services.
price ($mm)[EV]
$21 [$14]
rev ($mm)
$16
EBITDA ($mm)
EV / rev
0.9x
EV / EBITDA
closed 11/25/2020 via Company Press Release

Advarra, acquired Longboat Clinical Ltd.

See 284 Comparable Transactions
synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, is pleased to announce the acquisition of Longboat, an innovative provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
 target: Longboat Clinical Ltd.
Longboat is an innovative provider of user-friendly, fully mobile clinical research technology solutions that take the complexity out of trials for site staff, patients, monitors, and study teams, making protocol compliance easy and instinctive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/2/2020 via Company Press Release

Cytel Inc., acquired Laiya Consulting, Inc.

See 268 Comparable Transactions
synopsis: Cytel Inc. has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation. Laiya pioneered the delivery of trial design software using SaaS, which aligns with Cytel’s goal of making all of its design software available as a cloud-based service.
buyer parent: New Mountain Capital, LLC
buyer: Cytel Inc.
Cytel provides statistical software for clinical trials. Cytel provides an understanding of software tools that solve statistical problems and that meet the highest standards of reliability, technical documentation and customer support. "
 target: Laiya Consulting, Inc.
Founded in 2010, Laiya Consulting has supported drug developers to drive success rates and maximize portfolio returns through the design and implementation of Bayesian adaptive trials, robust clinical strategies, and integrated software platforms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/5/2016 via Company Press Release

Instem, acquired Notocord

See 376 Comparable Transactions
synopsis: Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it has acquired NOTOCORD. NOTOCORD provides software solutions for data acquisition and analysis in preclinical studies and is a recognized leader in cardiovascular, respiratory, electrophysiology and nervous system research areas.
buyer: Instem (AIM:INS:$38.90)
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide. "
 target: Notocord
Notocord, Inc. designs software and provides data acquisition, analysis, as well as reporting solutions. Their solutions are fit for preclinical R&D, including efficacy testing, early safety, regulatory safety pharmacology and toxicology studies.
price ($mm)
$2.25
rev ($mm)
$3
EBITDA ($mm)
EV / rev
2.0x
EV / EBITDA
Pages:  

By Image Solutions, Inc.


read more

Image Solutions, Inc.

Apyx, Inc.

read more

Image Solutions, Inc.

Apyx, Inc.

Axxiem Web Solutions

Phoenix Data Systems Inc.

Patient Profiles, LLC

PharmaCM

Bioinfogate S.L.

Allcyte

Medimix International

Relay Technology Management

Pinnacle 21

Comprehend Systems, Inc.

karmadata

Dataline Software

eClinical Insights, Inc.

eResearch Technology, Inc.

etrials, Inc.

Longboat Clinical Ltd.

Laiya Consulting, Inc.

Notocord

Pages:  
read more

Image Solutions, Inc.

Apyx, Inc.

Axxiem Web Solutions

Phoenix Data Systems Inc.

Patient Profiles, LLC

PharmaCM

Bioinfogate S.L.

Allcyte

Medimix International

Relay Technology Management

Pinnacle 21

Comprehend Systems, Inc.

karmadata

Dataline Software

eClinical Insights, Inc.

eResearch Technology, Inc.

etrials, Inc.

Longboat Clinical Ltd.

Laiya Consulting, Inc.

Notocord

Pages:  
Geography
Matching Companies
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.90
EBITDA ($mm)
$6.31
EBIT ($mm)
$5.20
Net Income ($mm)
$3.13
Employees
304
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: SLP
 
 
 
 
 
 
 
 
Simulations Plus, Inc.
Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software that is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide.
year
2019
rev ($mm)
$35.84
EBITDA ($mm)
$12.38
EBIT ($mm)
$11.28
Net Income ($mm)
$9.11
Employees
109
  • drill down
  • watch
Ticker: POAI
 
 
 
 
 
 
 
 
Predictive Oncology Inc.
Predictive Oncology Inc.
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. Predictive Oncology operates through five segments which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($13.26)
EBIT ($mm)
($13.71)
Net Income ($mm)
Employees
24
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2021
rev ($mm)
$914.37
EBITDA ($mm)
$99.36
EBIT ($mm)
$57.86
Net Income ($mm)
$35.01
Employees
2970
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: MRCY
 
 
 
 
 
 
 
 
Mercury Computer Systems, Inc.
Mercury Computer Systems, Inc.
Mercury Computer Systems is the leading supplier of high-performance digital signal and image processing systems. These embedded computer systems transform streams of sensor data to visual information in real time for analysis and interpretation.
year
2011
rev ($mm)
$228.71
EBITDA ($mm)
$33.90
EBIT ($mm)
$25.55
Net Income ($mm)
$18.44
Employees
602
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.90
EBITDA ($mm)
$6.31
EBIT ($mm)
$5.20
Net Income ($mm)
$3.13
Employees
304
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: SLP
 
 
 
 
 
 
 
 
Simulations Plus, Inc.
Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software that is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide.
year
2019
rev ($mm)
$35.84
EBITDA ($mm)
$12.38
EBIT ($mm)
$11.28
Net Income ($mm)
$9.11
Employees
109
  • drill down
  • watch
Ticker: POAI
 
 
 
 
 
 
 
 
Predictive Oncology Inc.
Predictive Oncology Inc.
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. Predictive Oncology operates through five segments which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($13.26)
EBIT ($mm)
($13.71)
Net Income ($mm)
Employees
24
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2021
rev ($mm)
$914.37
EBITDA ($mm)
$99.36
EBIT ($mm)
$57.86
Net Income ($mm)
$35.01
Employees
2970
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: MRCY
 
 
 
 
 
 
 
 
Mercury Computer Systems, Inc.
Mercury Computer Systems, Inc.
Mercury Computer Systems is the leading supplier of high-performance digital signal and image processing systems. These embedded computer systems transform streams of sensor data to visual information in real time for analysis and interpretation.
year
2011
rev ($mm)
$228.71
EBITDA ($mm)
$33.90
EBIT ($mm)
$25.55
Net Income ($mm)
$18.44
Employees
602
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch